News
Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...
To help you learn a little bit more about what you should and shouldn’t be eating, we’ve put together a list of foods that you might want to avoid if you’re a lupus patient (source: healthline.com): ...
In men that difference was lesser. Male patients with lupus lived a median of 61 years, and those in the public at large to age 73, a median 12-year difference. While septicemia and hypertension were ...
Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...
Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.
Columnist Marisa Zeppieri has learned much about chronic illness and work over the years she's lived with lupus, and she has some advice.
Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.
A lab study suggests that overproduction of a molecule called IFN-I, which promotes inflammation, may be due to mitochondrial injury, like oxidative stress.
Columnist Marisa Zeppieri shares her advice on how she and her husband work together to make the most out of their marriage despite illness.
Seattle Children's will start a clinical trial testing CAR T-cell therapy in children with lupus this summer after getting FDA clearance.
A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.
A Phase 2 trial of investigational therapy zetomipzomib is seeking adult systemic lupus erythematosus (SLE) patients with lupus nephritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results